Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.11
Delayed Data
As of Jul 27
 +0.06 / +0.66%
Today’s Change
5.26
Today|||52-Week Range
9.54
+15.76%
Year-to-Date

Today’s Trading

Previous close9.05
Today’s open8.80
Day’s range8.79 - 9.28
Volume444,097
Average volume (3 months)467,542
Market cap$697.9M
Dividend yield--
Data as of 3:59pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+104.76%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book3.28

Competitors

 Today’s
change
Today’s
% change
FMIFoundation Medicine ...+0.54+2.41%
GHDXGenomic Health Inc+0.44+1.56%
GNMKGenMark Diagnostics ...+0.13+1.30%
RDNTRadNet Inc+0.03+0.51%
Data as of 3:59pm ET, 07/27/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers

Search for Jobs